)
)
)
MacroLink
Macrolink (MLK) is focusing on the next generation of ADC product R&D. Product pipeline includes new targets (FIC) ADC and bispecific ADC (FIC）using pioneer technologies. The MLK technology platform (MlkCore) is standing out from classic ADC technologies, its innovations focus on the CQA of ADC to increase its efficacy and safety:
· Novel antibody design with high tumor penetration.
· New site-specific conjugation at the optimal position, shielded from the blood stream to increase the stability and decrease hydrophobicity and immunogenicity。
· Stable linker and conjugation to minimize off target toxicity and widen therapeutical window.
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)